Arvina’s BCL6 protein degrader shows high antiproliferative activity
June 18, 2024
B-cell lymphoma 6 (BCL6) is up-regulated in several B-cell malignancies where it acts as a transcription factor activity mediator to induce and maintain lymphomagenesis.